The merger is seen as a way to diversify and strengthen NLS’s pipeline, incorporating Kadimastem’s innovative technologies into the portfolio. It also opens the door for Kadimastem to become a ...
Wayne-based Palvella Therapeutics recently finalized a reverse merger with Pieris Pharmaceutical, transitioning into a publicly traded company while securing a significant cash infusion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback